| 產(chǎn)品名稱 |
Bovine herpesvirus 1 |
| 商品貨號(hào) |
B226461 |
| Classification |
Herpesviridae, Varicellovirus |
| Deposited As |
Infectious bovine rhinotracheitis |
| Agent |
Bovine herpesvirus 1 |
| Strain |
RLB-106 |
| Common Name |
Infectious bovine rhinotracheitis virus, Bovine rhinotracheitis virus |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Nasal swab obtained from bovine with symptoms typical of infectious bovine rhinotracheitis |
| Product Format |
frozen |
| Storage Conditions |
-70°C |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Comments |
The RLB-106 strain is a temperature-sensitive mutant with cut-off temperature of 39-39.5°C. Highly effective as vaccine strain when administered by intranasal route. This item has been grown in the presence of penicillin and streptomycin. |
| Effect on Host |
tumorigenicity: Cytopathic effects in tissue culture |
| Recommended Host |
bovine kidney cells bovine kidney cells in tissue culture |
| Growth Conditions |
Temperature: 39.5°C Incubation: 3-4 days |
| Name of Depositor |
Norden Labs. |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
Nasal swab obtained from bovine with symptoms typical of infectious bovine rhinotracheitis |
| References |
Zygraich N, Lobmann M. Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof. US Patent 3,907,986 dated Sep 23 1975
|
